Table 3.

Mean difference (MD)^a with 95% CI in each group and the whole study population, paired samples t-test comparing start to 8 weeks’ follow-up

	Norvegia®			Gamalost®			Control			Study population
Variable	MD	95% CI	p	MD	95% CI	p	MD	95% CI	p	MD	95% CI	p
Total chol (mmol/L)	−0.20	−0.37, −0.04	0.017	−0.09	−0.23, 0.05	0.215	−0.07	−0.25, 0.12	0.477	−0.12	−0.21, −0.03	0.013
LDL chol (mmol/L)	−0.07	−0.21, 0.07	0.342	0.00	−0.12, 0.11	0.959	−0.07	−0.21, 0.07	0.292	−0.05	−0.12, 0.03	0.212
TAG (mmol/L)	−0.06	−0.18, 0.06	0.324	0.02	−0.08, 0.12	0.751	0.13	−0.10, 0.36	0.259	0.03	−0.06, 0.12	0.530
Waist (cm)	−1.0	−1.5, −0.4	0.001	−1.6	−2.1, −1.1	<0.001	−1.0	−1.6, 0.5	0.001	−1.2	−1.5, −0.9	<0.001
SBP (mmHg)	−3.5	−5.8, −1.3	0.003	−4.4	−7.0, −1.8	0.001	−5.4	−8.5, −2.2	0.001	−4.4	−6.0, −2.9	<0.001
DBP (mmHg)	−0.9	−2.6, 0.9	0.319	−2.9	−4.4, −1.4	<0.001	−1.1	−3.3, 1.1	0.333	−1.6	−2.7, −0.6	0.002
Glucose (mmol/L)	0.09	−0.11, 0.28	0.368	0.20	0.00, 0.41	0.051	0.05	−0.16, 0.26	0.634	0.12	0.00, 0.23	0.049
HDL-chol (mmol/L)	−0.04	−0.10, 0.03	0.299	−0.06	−0.10, −0.01	0.010	−0.04	−0.10, 0.01	0.100	−0.05	−0.08, −0.01	0.004

^aFor baseline values, see Table 2.